TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 128 filers reported holding TREACE MED CONCEPTS INC in Q4 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 750,000 | $4,987,500 | 2.25% |
Soleus Capital Management, L.P. | 2,365,648 | $15,731,559 | 1.39% |
GAGNON SECURITIES LLC | 483,581 | $3,215,814 | 0.72% |
ARMISTICE CAPITAL, LLC | 5,360,000 | $35,644,000 | 0.45% |
Divisadero Street Capital Management, LP | 114,400 | $760,760 | 0.12% |
GSA CAPITAL PARTNERS LLP | 191,427 | $1,273 | 0.09% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 212,976 | $1,416,290 | 0.09% |
KORNITZER CAPITAL MANAGEMENT INC /KS | 526,918 | $3,504,005 | 0.07% |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 3,681,718 | $24,483,425 | 0.06% |
Lighthouse Investment Partners, LLC | 167,500 | $1,113,875 | 0.04% |